Manish Kumar

MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma

S. Pinto, Arun H. Patil, Vishalakshi Nanjappa, 2019, Scientific Reports.

A Mini-review on HER2 Positive Breast Cancer and its Metastasis: Resistance and Treatment Strategies

Manish Kumar, P. Rajnikanth, M. Rajnikanth, 2020 .

MOLECULAR PLAYERS OF LUNG CARCINOMA

Manish Kumar, A. Singh, S. Prakash, 2016 .

Molecular Classification of Breast Carcinoma Based on the Prognostic Marker: A Clinico-pathological Correlation

U. Kumar, K. Chandra, R. Singh, 2022, Journal of Advances in Medicine and Medical Research.

How to Achieve Therapeutic Response in Erlotinib-Resistant Head and Neck Squamous Cell Carcinoma? New Insights from Stable Isotope Labeling with Amino Acids in Cell Culture-Based Quantitative Tyrosine Phosphoproteomics.

S. Pinto, Vishalakshi Nanjappa, A. Radhakrishnan, 2021, Omics : a journal of integrative biology.

Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials

Manish Kumar, Avinash C. Pandey, Shivkant Singh, 2018 .

Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells

Mallika Alvala, S. Ramakrishna, Dinesh Thummuri, 2014, Apoptosis.

Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells

Mallika Alvala, S. Ramakrishna, Dinesh Thummuri, 2014, Apoptosis.